{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:39:44Z","timestamp":1761197984986},"reference-count":37,"publisher":"Japanese Society of Veterinary Science","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1292\/jvms.21-0350","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T22:08:28Z","timestamp":1631570908000},"page":"1694-1701","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of a mouse- and egg-adapted strain for the evaluation of vaccine potency against H3N2 variant influenza virus in mice"],"prefix":"10.1292","volume":"83","author":[{"given":"Enkhbold","family":"BAZARRAGCHAA","sequence":"first","affiliation":[{"name":"Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"HIONO","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"ISODA","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan"},{"name":"International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Kita 20, Nishi 10, Kita-ku, Sapporo, Hokkaido 001-0020, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"HAYASHI","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"OKAMATSU","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"SAKODA","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-ku, Sapporo, Hokkaido 060-0818, Japan"},{"name":"International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Kita 20, Nishi 10, Kita-ku, Sapporo, Hokkaido 001-0020, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Barman, S., Franks, J., Turner, J. C., Yoon, S. W., Webster, R. G. and Webby, R. J. 2015. Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity. <i>Vaccine<\/i> 33: 3186\u20133192.","DOI":"10.1016\/j.vaccine.2015.05.011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Caldera, F., Mercer, M., Samson, S. I., Pitt, J. M. and Hayney, M. S. 2021. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity. <i>Vaccine<\/i> 39 Suppl 1: A15\u2013A23.","DOI":"10.1016\/j.vaccine.2020.11.037"},{"key":"3","unstructured":"3. Centers for Disease Control and Prevention. 2020. How influenza (Flu) vaccines are made? https:\/\/www.cdc.gov\/flu\/prevent\/how-fluvaccine-made.htm [accessed on June 7, 2021]."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chien, C. Y., Xu, Y., Xiao, R., Aramini, J. M., Sahasrabudhe, P. V., Krug, R. M. and Montelione, G. T. 2004. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. <i>Biochemistry<\/i> 43: 1950\u20131962.","DOI":"10.1021\/bi030176o"},{"key":"5","unstructured":"5. European Medicines Agency. 2017. Guidence on influenza vaccine \u2212Quality module. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-influenza-vaccines-quality-module-revision-1_en.pdf [assessed on Aug 16, 2021]."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hayashi, H., Isoda, N., Bazarragchaa, E., Nomura, N., Matsuno, K., Okamatsu, M., Kida, H. and Sakoda, Y. 2020. Potency of an inactivated influenza vaccine against a challenge with A\/Swine\/Missouri\/A01727926\/2015 (H4N6) in mice for pandemic preparedness. <i>Vaccines (Basel)<\/i> 8: 1\u20138.","DOI":"10.3390\/vaccines8040768"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hoffmann, E., Stech, J., Guan, Y., Webster, R. G. and Perez, D. R. 2001. Universal primer set for the full-length amplification of all influenza A viruses. <i>Arch. Virol.<\/i> 146: 2275\u20132289.","DOI":"10.1007\/s007050170002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Houser, K. V., Pearce, M. B., Katz, J. M. and Tumpey, T. M. 2013. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. <i>J. Virol.<\/i> 87: 13480\u201313489.","DOI":"10.1128\/JVI.02434-13"},{"key":"9","unstructured":"9. Howley, M. and Knipe, D. 2020. <i>Orthomyxoriruses<\/i>. pp. 649\u2013673. In: Fields Virology: Emerging Viruses, 7th ed., Wolters Kluwer, Philadelphia."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Johnson, C., Hohenboken, M., Poling, T., Jaehnig, P. and Kanesa-Thasan, N. 2015. Safety and immunogenicity of cell culture-derived A\/H3N2 variant influenza vaccines: a phase I randomized, observer-blind, dose-ranging study. <i>J. Infect. Dis.<\/i> 212: 72\u201380.","DOI":"10.1093\/infdis\/jiu826"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kameyama, K., Sakoda, Y., Tamai, K., Igarashi, H., Tajima, M., Mochizuki, T., Namba, Y. and Kida, H. 2006. Development of an immunochromatographic test kit for rapid detection of bovine viral diarrhea virus antigen. <i>J. Virol. Methods<\/i> 138: 140\u2013146.","DOI":"10.1016\/j.jviromet.2006.08.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kaplan, B. S., Kimble, J. B., Chang, J., Anderson, T. K., Gauger, P. C., Janas-Martindale, A., Killian, M. L., Bowman, A. S. and Vincent, A. L. 2020. Aerosol transmission from infected swine to ferrets of an H3N2 virus collected from an agricultural fair and associated with human variant infections. <i>J. Virol.<\/i> 94: 1\u201315.","DOI":"10.1128\/JVI.01009-20"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Keitel, W. A., Jackson, L. A., Edupuganti, S., Winokur, P. L., Mulligan, M. J., Thornburg, N. J., Patel, S. M., Rouphael, N. G., Lai, L., Bangaru, S., McNeal, M. M., Bellamy, A. R., Hill, H. R., VTEU H3N2v Vaccine Study Work Group. 2015. Safety and immunogenicity of a subvirion monovalent unadjuvanted inactivated influenza A(H3N2) variant vaccine in healthy persons \u226518 years old. <i>J. Infect. Dis.<\/i> 212: 552\u2013561.","DOI":"10.1093\/infdis\/jiv056"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kida, H., Brown, L. E. and Webster, R. G. 1982. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A\/Seal\/Massachusetts\/1\/80 (H7N7) influenza virus. <i>Virology<\/i> 122: 38\u201347.","DOI":"10.1016\/0042-6822(82)90375-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kirihara, Y., Takechi, M., Kurosaki, K., Kobayashi, Y. and Kurosawa, T. 2013. Anesthetic effects of a mixture of medetomidine, midazolam and butorphanol in two strains of mice. <i>Exp. Anim.<\/i> 62: 173\u2013180.","DOI":"10.1538\/expanim.62.173"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kishida, N., Fujisaki, S., Yokoyama, M., Sato, H., Saito, R., Ikematsu, H., Xu, H., Takashita, E., Tashiro, M., Takao, S., Yano, T., Suga, T., Kawakami, C., Yamamoto, M., Kajiyama, K., Saito, H., Shimada, S., Watanabe, S., Aoki, S., Taira, K., Kon, M., Lin, J. H. and Odagiri, T. 2012. Evaluation of influenza virus A\/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A\/H3N2 and B isolated in MDCK cells and embryonated hen eggs. <i>Clin. Vaccine Immunol.<\/i> 19: 897\u2013908.","DOI":"10.1128\/CVI.05726-11"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kodihalli, S., Justewicz, D. M., Gubareva, L. V. and Webster, R. G. 1995. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. <i>J. Virol.<\/i> 69: 4888\u20134897.","DOI":"10.1128\/jvi.69.8.4888-4897.1995"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kumar, A., Meldgaard, T. S. and Bertholet, S. 2018. Novel platforms for the development of a universal influenza vaccine. <i>Front. Immunol.<\/i> 9: 600.","DOI":"10.3389\/fimmu.2018.00600"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lindstrom, S., Garten, R., Balish, A., Shu, B., Emery, S., Berman, L., Barnes, N., Sleeman, K., Gubareva, L., Villanueva, J. and Klimov, A. 2012. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. <i>Emerg. Infect. Dis.<\/i> 18: 834\u2013837.","DOI":"10.3201\/eid1805.111922"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Loving, C. L., Lager, K. M., Vincent, A. L., Brockmeier, S. L., Gauger, P. C., Anderson, T. K., Kitikoon, P., Perez, D. R. and Kehrli, M. E. Jr. 2013. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011\u20132012 H3N2v. <i>J. Virol.<\/i> 87: 9895\u20139903.","DOI":"10.1128\/JVI.01038-13"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lu, B., Zhou, H., Ye, D., Kemble, G. and Jin, H. 2005. Improvement of influenza A\/Fujian\/411\/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. <i>J. Virol.<\/i> 79: 6763\u20136771.","DOI":"10.1128\/JVI.79.11.6763-6771.2005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mostafa, A., Abdelwhab, E. M., Mettenleiter, T. C. and Pleschka, S. 2018. Zoonotic potential of influenza A viruses: a comprehensive overview. <i>Viruses<\/i> 10: 1\u201338.","DOI":"10.3390\/v10090497"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nelson, M. I., Viboud, C., Vincent, A. L., Culhane, M. R., Detmer, S. E., Wentworth, D. E., Rambaut, A., Suchard, M. A., Holmes, E. C. and Lemey, P. 2015. Global migration of influenza A viruses in swine. <i>Nat. Commun.<\/i> 6: 6696.","DOI":"10.1038\/ncomms7696"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okamatsu, M., Sakoda, Y., Hiono, T., Yamamoto, N. and Kida, H. 2013. Potency of a vaccine prepared from A\/swine\/Hokkaido\/2\/1981 (H1N1) against A\/Narita\/1\/2009 (H1N1) pandemic influenza virus strain. <i>Virol. J.<\/i> 10: 47.","DOI":"10.1186\/1743-422X-10-47"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ping, J., Keleta, L., Forbes, N. E., Dankar, S., Stecho, W., Tyler, S., Zhou, Y., Babiuk, L., Weingartl, H., Halpin, R. A., Boyne, A., Bera, J., Hostetler, J., Fedorova, N. B., Proudfoot, K., Katzel, D. A., Stockwell, T. B., Ghedin, E., Spiro, D. J. and Brown, E. G. 2011. Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. <i>PLoS One<\/i> 6: e21740.","DOI":"10.1371\/journal.pone.0021740"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Reed, L. J. and Muench, H. 1938. A simple method of estimating fifty per cent endpoints. <i>Am. J. Hyg.<\/i> 27: 493\u2013497.","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rogers, G. N., Daniels, R. S., Skehel, J. J., Wiley, D. C., Wang, X. F., Higa, H. H. and Paulson, J. C. 1985. Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A\/duck\/Ukraine\/1\/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. <i>J. Biol. Chem.<\/i> 260: 7362\u20137367.","DOI":"10.1016\/S0021-9258(17)39617-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sakabe, S., Ozawa, M., Takano, R., Iwastuki-Horimoto, K. and Kawaoka, Y. 2011. Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. <i>Virus Res.<\/i> 158: 124\u2013129.","DOI":"10.1016\/j.virusres.2011.03.022"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Schicker, R. S., Rossow, J., Eckel, S., Fisher, N., Bidol, S., Tatham, L., Matthews-Greer, J. and Sohner, K. 2016. Outbreak of influenza A(H3N2) variant virus infections among persons attending agricultural fairs housing infected swine\u2014Michigan and Ohio, July\u2013August 2016. pp. 1\u20134. In: Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6542a1.htm [assessed on June 2, 2021].","DOI":"10.15585\/mmwr.mm6542a1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Skowronski, D. M., Janjua, N. Z., De Serres, G., Purych, D., Gilca, V., Scheifele, D. W., Dionne, M., Sabaiduc, S., Gardy, J. L., Li, G., Bastien, N., Petric, M., Boivin, G. and Li, Y. 2012. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). <i>J. Infect. Dis.<\/i> 206: 1852\u20131861.","DOI":"10.1093\/infdis\/jis500"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sun, X., Pulit-Penaloza, J. A., Belser, J. A., Pappas, C., Pearce, M. B., Brock, N., Zeng, H., Creager, H. M., Zanders, N., Jang, Y., Tumpey, T. M., Davis, C. T. and Maines, T. R. 2018. Pathogenesis and transmission of genetically diverse swine-origin H3N2 variant influenza A viruses from multiple lineages isolated in the United States, 2011\u20132016. <i>J. Virol.<\/i> 92: 1\u201315.","DOI":"10.1128\/JVI.00665-18"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tate, M. D., Job, E. R., Brooks, A. G. and Reading, P. C. 2011. Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. <i>Virology<\/i> 413: 84\u201392.","DOI":"10.1016\/j.virol.2011.01.036"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Tseng, Y. C., Wu, C. Y., Liu, M. L., Chen, T. H., Chiang, W. L., Yu, Y. H., Jan, J. T., Lin, K. I., Wong, C. H. and Ma, C. 2019. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections. <i>Proc. Natl. Acad. Sci. USA<\/i> 116: 4200\u20134205.","DOI":"10.1073\/pnas.1819197116"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wilson, A. I., Skehel, J. J. and Wiley, D. C. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution. <i>Nature<\/i> 289: 367\u2013373.","DOI":"10.1038\/289366a0"},{"key":"35","unstructured":"35. World Health Organization. 2021. Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. pp. 88\u2013104. In: Weekly Epidemiological Record, 96. https:\/\/apps.who.int\/iris\/handle\/10665\/340335 [assessed on August 17, 2021]."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ye, Q., Krug, R. M. and Tao, Y. J. 2006. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. <i>Nature<\/i> 444: 1078\u20131082.","DOI":"10.1038\/nature05379"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ye, Z., Liu, T., Offringa, D. P., McInnis, J. and Levandowski, R. A. 1999. Association of influenza virus matrix protein with ribonucleoproteins. <i>J. Virol.<\/i> 73: 7467\u20137473.","DOI":"10.1128\/JVI.73.9.7467-7473.1999"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/83\/11\/83_21-0350\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:47:59Z","timestamp":1715143679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/83\/11\/83_21-0350\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.21-0350","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"21-0350"}}